BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28239924)

  • 1. Cannabinoids as gastrointestinal anti-inflammatory drugs.
    Fabisiak A; Fichna J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28239924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and the gastrointestinal tract.
    Massa F; Monory K
    J Endocrinol Invest; 2006; 29(3 Suppl):47-57. PubMed ID: 16751708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role for GPR55 in gastrointestinal functions.
    Schicho R; Storr M
    Curr Opin Pharmacol; 2012 Dec; 12(6):653-8. PubMed ID: 23063456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine.
    Smid SD
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1383-7. PubMed ID: 18671715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
    Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
    Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid pharmacology and therapy in gut disorders.
    Uranga JA; Vera G; Abalo R
    Biochem Pharmacol; 2018 Nov; 157():134-147. PubMed ID: 30076849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastrointestinal pharmacology of cannabinoids: focus on motility.
    Abalo R; Vera G; López-Pérez AE; Martínez-Villaluenga M; Martín-Fontelles MI
    Pharmacology; 2012; 90(1-2):1-10. PubMed ID: 22699400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms.
    Pesce M; Esposito G; Sarnelli G
    Curr Opin Pharmacol; 2018 Dec; 43():81-86. PubMed ID: 30218940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
    Hasenoehrl C; Taschler U; Storr M; Schicho R
    Neurogastroenterol Motil; 2016 Dec; 28(12):1765-1780. PubMed ID: 27561826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastrointestinal pharmacology of cannabinoids: an update.
    Coutts AA; Izzo AA
    Curr Opin Pharmacol; 2004 Dec; 4(6):572-9. PubMed ID: 15525546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.
    Massa F; Storr M; Lutz B
    J Mol Med (Berl); 2005 Dec; 83(12):944-54. PubMed ID: 16133420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
    Schicho R; Storr M
    Can J Gastroenterol; 2011 Jul; 25(7):377-83. PubMed ID: 21876860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
    Di Carlo G; Izzo AA
    Expert Opin Investig Drugs; 2003 Jan; 12(1):39-49. PubMed ID: 12517253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system and its therapeutic exploitation.
    Di Marzo V; Bifulco M; De Petrocellis L
    Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.
    Izzo AA; Camilleri M
    Gut; 2008 Aug; 57(8):1140-55. PubMed ID: 18397936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids for the treatment of inflammation.
    Ashton JC
    Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.